SAVE THE DATE! How can you best identify at-risk relatives for Alagille syndrome (ALGS)? Join our 15-min live expert panel to discuss family-based genetic screening and unlock early treatment strategies. 🗓️ Nov 25th 🕚 11:45AM ET 🔗 youtube.com/watch?v=UHdDuo… #CME

Watch LIVE Tomorrow! ➡️ youtube.com/watch?v=VqQVpa… Transform your MASH management. Our experts, Drs. Schattenberg, Alkhouri, & Thiele, unpack the clinical data behind recent approvals and share strategies to improve patient outcomes. #CME

MASH: To Treat or Not to Treat? Experts discuss the cutting edge in metabolic liver disease, from using advanced diagnostics to guide new, approved therapies. The goal is to bridge the gap from research to real-world clinical decision-making ➡️ x.com/Medscape/statu…

From aimless searches to focused responses. Here's why experts like Dr. F. Perry Wilson trust Medscape AI. Try it here: medscape.com/ai-search?quer… #ad

The Oncology Brothers, Dr. Nina Vijayvergia, and Dr. Tiago Biachi break down the data, dosing, and toxicity management that guides their real-world sequencing decisions in refractory mCRC. Watch the full stream ➡️ x.com/i/broadcasts/1… #CME #Oncology #mCRC

In MASH, the FAST score helps identify patients at risk for progression. This noninvasive tool combines markers of steatosis (CAP), inflammation (ACT), and fibrosis (VCTE) to guide clinical decisions. Learn the Latest! ➡️ ms.spr.ly/6015SO2Ch

Are you applying the latest MASH guidelines correctly? Join our expert faculty as they discuss the nuances of non-invasive tests and how to identify high-risk patients in your everyday practice. Watch the full discussion ➡️ x.com/i/broadcasts/1… #CME #MASH #Fibrosis

Watch LIVE in 1 HOUR! ➡️ youtube.com/watch?v=VqQVpa… MASH care is evolving. Are you up to date on the latest guideline recommendations and noninvasive testing strategies? Join our experts now! #CME

Do you treat patients with high triglycerides? How do you distinguish FCS from multifactorial hypertriglyceridemia? Get diagnostic pearls & explore new APOC3-targeted therapies with Dr. Shapiro. 📅 November 24 ⏰ 5:15pm ET 🔗 youtube.com/watch?v=NzkbCi… #Cardiology #CME

What are the best-practice approaches for family-based screening in Alagille syndrome? We'll explore the genetic basis of ALGS, phenotypic variability, and available genetic panel options in just 15 minutes. 🗓️ November 25th 🕚 11:45 AM ET 🔗 youtube.com/watch?v=UHdDuo…

Listen as Dr. Russ Cohen and Dr. Anita Afzali discuss quick fire questions on IBD treatments, when to move to second-line therapy, and how to choose the best options for patients. Shared decision-making is key. ▶️ ms.spr.ly/6016tTYny

Watch LIVE Tomorrow! ➡️ youtube.com/watch?v=NzkbCi… Get actionable strategies for using APOC3 inhibitors in FCS patients. Join expert Dr. Michael Shapiro for a 15-min checkpoint. ⏰ 5:15pm ET #Cardiology #CME

Watch LIVE Tomorrow! ➡️ youtube.com/watch?v=UHdDuo… Transform your approach to Alagille syndrome. Our panel will share critical insights on implementing genetic screening for family members to enable early treatment strategies. Not to be missed! #AlagilleSyndrome #CME

Watch LIVE in 1 HOUR! ➡️ youtube.com/watch?v=NzkbCi… Are you up to date on APOC3 inhibitors for FCS? Get the latest clinical data and practical management tips from Dr. Michael Shapiro. Join us at 5:15 PM ET! #Cardiology #CME

Watch LIVE in 1 HOUR! ➡️ youtube.com/watch?v=UHdDuo… Improving patient outcomes starts with translating evidence into practice. Learn how to identify at-risk relatives for Alagille syndrome - and earn credits! #AlagilleSyndrome #CME

Are you ready for the transition in metabolic liver management? We're sharing practical guidance for your everyday clinical decisions and seeing how new research is being implemented in the real world. Watch the full video ➡️ x.com/Medscape/statu… #MASH #CME

Tobacco use + T2DM = a higher risk of fibrosis in MASLD. Be sure to screen your patients who smoke regularly as smoking accelerates liver disease progression, making early detection critical. Don't Miss New MASH Advances! ➡️ ms.spr.ly/6011SONPD

The conversation on liver health is shifting. Experts discuss the move from waiting for symptoms to acting early. See how new developments are helping doctors treat the disease before it becomes a problem. Watch the full video ➡️ x.com/Medscape/statu…

Does a child's diagnosis unlock a family mystery? Patient advocate Sean P. Kelley shares how his daughter’s facial features led to a surprise Alagille Syndrome diagnosis for his wife. Learn the critical importance of family-based genetic screening ➡️ x.com/i/broadcasts/1…

Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk ➡️ x.com/i/broadcasts/1… #CME